Implementation of ▼REZZAYO® Rezafungin through formulary submission
Implementation of ▼REZZAYO® Rezafungin through formulary submission
Get access to exclusive content and news updates:
33.37 
English 
Stephen Hughes
Antimicrobial Pharmacist MPharm, MSc, MBA
Watch as Consultant Antimicrobial Pharmacist Stephen Hughes talks about REZZAYO® and his experience with submitting for formulary at the Chelsea & Westminster NHS Trust.
Related Webinars
▼REZZAYO® Patient Case Study - Pharmacist Ahmad Simreekheea
▼REZZAYO® (rezafungin) Patient Case Study - Pharmacist Ahmad Simreekheea
Ahmad Simreekheea
Watch as Ahmad Simreekheea discusses his experience with using REZZAYO(R) in a patient case study.
Ahmad Simreekheea
Antimicrobial Pharmacist, MSc
Video descripton: Watch as Ahmad Simreekheea discusses his experience with using REZZAYO® in a patient case study.
Introducing ▼ REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.
Introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.
Professor Tihana Bicanic Professor Oliver Cornely Professor Matteo Bassetti
Launch webinar introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 Speakers Professor Tihana Bicanic, Professor Oliver Cornley and Matteo Bassetti present.
Professor Tihana Bicanic
Reader and Consultant in Infectious diseases at St George's University of London.